Navigation Links
Researchers Find RapidArc® Radiotherapy from Varian Medical Systems Can Quickly and Accurately Deliver Total Marrow Irradiation (TMI) Treatments for Patients with Blood Cancers
Date:8/8/2011

PALO ALTO, Calif., Aug. 8, 2011 /PRNewswire/ -- RapidArc® radiotherapy from Varian Medical Systems (NYSE: VAR) can be used to treat patients with blood cancers by quickly and accurately delivering "clinically favorable" total marrow irradiation (TMI), according to a team of noted cancer treatment experts who spoke at the 2011 joint meeting of the American Association of Physicists in Medicine (AAPM) and the Canadian Organization of Medical Physicists (COMP) in Vancouver last week.  Their recent study on this topic, which is available online as an article in press ahead of publication, is slated to appear in an upcoming issue of the International Journal of Radiation Oncology*Biology*Physics.(1)

"Compared to conventional IMRT and tomotherapy, RapidArc appears to improve on the dose distribution, in terms of normal tissue sparing, as well as on the efficiency of treatment," said Bulent Aydogan, PhD, associate professor of medical physics at the University of Chicago and the director of medical physics at the University of Illinois at Chicago.

Aydogan and his collaborators planned and delivered, in their recent dosimetric feasibility study, RapidArc TMI treatments for six patients, and subsequently compared the treatment plan parameters, including median dose, mean dose, and maximum dose, to fixed-gantry and tomotherapy plans for the same cases.  They found that RapidArc produces dose distributions that are comparable to conventional intensity-modulated radiotherapy (IMRT) in terms of target coverage, but with improved normal tissue sparing.  

The RapidArc treatments could also be delivered much more efficiently, requiring approximately 18 minutes once a patient was positioned for treatment.  By comparison, treatment times of 45 to 50 minutes have be
'/>"/>

SOURCE Varian Medical Systems
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Researchers Present Key Findings Comparing PEM to MRI for Identification of Contralateral Breast Cancer at the National Consortium of Breast Centers (NCBC) Conference
2. Cannabis Science Forms Military Advisory Board That Will Be Comprised of Distinguished Military Leaders, Military Health Care Providers, Researchers and Educators Headed Up by Lieutenant Colonel, U.S. Army (Ret) Kevin Sullivan
3. Chemistry Researchers Create New Tool to Visualize Bloodstains
4. UPDATED: Elsevier Online Opinion Survey Reveals Researchers Ready to Push Scientific Search and Discovery to the Next Level
5. CulGenex™ by Hardy Diagnostics Assists Medical Researchers!
6. Researchers Use Nanoparticles as Destructive Beacons to Zap Tumors
7. Elsevier Appoints Top Diabetes and Endocrinology Researchers as Editors
8. Karmanos Cancer Institute Researchers Study Bisphosphonates and Their Affect on Early Stage Breast Cancer
9. Drexel Biomedical Researchers Develop Device to Predict Diabetic Wound Healing
10. Researchers at MD Anderson Show That Positron Emission Mammography (PEM) Helps Evaluate Early Response to Neoadjuvant Chemotherapy
11. SRI International Researchers Present Promising New Therapeutic for the Treatment of Multiple Myeloma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... Conn. , May 17, 2013 /PRNewswire-iReach/ -- ... and recombinant proteins, is placing renewed emphasis on ... the rise as a number of factors are ... for pharmaceutical makers and their delivery device partners ... previously refractory conditions, the growing trend toward self-administration ...
(Date:5/17/2013)... May 17, 2013  Boehringer Ingelheim will contribute ... at the American Thoracic Society International Conference (ATS ... May 17 – 22. Data will ... the treatment of chronic obstructive pulmonary disease (COPD) ... as investigational compounds for asthma, idiopathic pulmonary fibrosis ...
(Date:5/17/2013)... 2013  Sanofi (EURONEXT: SAN and NYSE: SNY ... JAKARTA , examining the selective JAK2 inhibitor SAR302503 ... dose groups. The primary endpoint assessed the proportion of ... data reported in previous trials, the most common adverse ... will be presented at an upcoming medical congress. ...
Breaking Medicine Technology:Pharmaceutical Makers and Delivery Device Partners Rethink Delivery Technologies - New Report Examines this Evolving Segment 2Pharmaceutical Makers and Delivery Device Partners Rethink Delivery Technologies - New Report Examines this Evolving Segment 3Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 2Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 3Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 4Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 5Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 6Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 7Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 8Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 2Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 3Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 4Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 5Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 6
... 12, 2011 Unilife Corporation ("Unilife" or the "Company") ... the development of its AutoInfusor™ portfolio of subcutaneous infusion ... 5mL, 7mL, and 10mL volumes. Unilife has ... of pharmaceutical and biotechnology companies with drugs that have ...
... one of the largest distributors of high-performance and engineering-grade ... new EVONIK VESTAKEEP® 5000 PEEK extruded stock shapes. ... most ductility of any PEEK material available in extruded ... Marketing at Modern Plastics. EVONIK VESTAKEEP® ...
Cached Medicine Technology:Unilife Develops Proprietary Portfolio of Wearable Subcutaneous Infusion Devices for the Self-Administration of Large Volume Drugs by Patients 2Unilife Develops Proprietary Portfolio of Wearable Subcutaneous Infusion Devices for the Self-Administration of Large Volume Drugs by Patients 3Unilife Develops Proprietary Portfolio of Wearable Subcutaneous Infusion Devices for the Self-Administration of Large Volume Drugs by Patients 4
(Date:5/18/2013)... (PRWEB) May 18, 2013 Adolescents, especially ... known as “Spice” or “K2” are landing in emergency ... to curb this drug epidemic with a new ... marijuana. , According to research from the National Institute ... popular illegal drug among American teenagers. In 2012, 11 ...
(Date:5/18/2013)... DF (PRWEB) May 18, 2013 The ... leading ayurvedic education institution in the West. Program is ... education. , Ayurveda is a healing modality practiced for ... ), it is considered that health begins when an ... profound understanding of their individual needs. Ayurveda aims to ...
(Date:5/18/2013)... Bay, CA (PRWEB) May 18, 2013 ... , has recently completed a stylish renovation that features ... advanced specialties. , From the ground up, this ... improved with fresh flooring, soothing colors and comfortable spa ... been installed, including an Apilus epilator machine. The ...
(Date:5/18/2013)... 2013 Losing weight remains to be the ... horde of new weight loss products available in the market ... studies about this newest weight loss supplement prove that dieting ... , Garcinia Cambogia is a sub-tropical fruit that is shaped ... fruit can suppress a person’s appetite, while it effectively burns ...
(Date:5/18/2013)... Spectrum Surgical Instruments will attend ... in Austin, TX where thousands of GI nursing ... opportunities. , Spectrum Surgical/STERIS will feature its ... capabilities and certified pre-owned equipment. Attendees will ... proper instrument care of flexible endoscopes. , ...
Breaking Medicine News(10 mins):Health News:Spice Addiction Treatment and Synthetic Marijuana Drug Rehab Announced by Recovery Associates 2Health News:Ayurveda Training in Mexico Offered by Escuela de Ayurveda de California, a Leading Institution in the West 2Health News:Rio Salon and Spa, a Beauty Salon in Morro Bay, Undergoes Makeover 2Health News:Lose Weight Without Dieting or Exercising with Garcinia Cambogia Select Now Available At HealthCareSupplementz.com 2Health News:Spectrum Surgical Attends Society of Gastroenterology Nurses and Associates' (SGNA) 40th Annual Conference in Austin, TX 2
... ... inactivating 99.9% of the flu virus. The filter has been treated with Coway,s anti-viral ... ... 2009 -- Coway ,s new anti-flu air filter was recently tested for ...
... The Ensign Group, Inc. (Nasdaq: ENSG ), ... nursing, rehabilitative care services, hospice care and assisted living ... Oppenheimer & Co. 20th Annual Healthcare Conference on November ... http://www.newscom.com/cgi-bin/prnh/20071213/LATH168LOGO ) , Christopher Christensen, the company,s ...
... Keystone ... and administer health screenings. , ... Philadelphia, Pa. October 27, 2009 – More than 250 West Philadelphia men, ... part of the Health Ministry Program, hosted by Keystone Mercy Health Plan, the largest ...
... ... an Impact as Inaugural President , ... Grand Rapids, Mich. (Vocus) October 29, 2009 -- Sanford-Brown Institute (SBI) - Grand ... first campus president. Amidon comes to SBI - Grand Rapids from Baker College in Muskegon, ...
... Smith & Nephew,s (NYSE: SNN ; LSE: ... first-of-its-kind contribution to the Center for Orthopaedic Trauma Advancement ... Smith & Nephew and COTA entered into a grant ... as an independent, third-party administrator of funds. Smith ...
... autoimmune disease scleroderma can discolor parts of the skin of ... harden their skin, their blood vessels, and their internal organs ... forms, scleroderma gives Dartmouth geneticist Michael Whitfield, his graduate students, ... search for the triggers of the chronic condition. In a ...
Cached Medicine News:Health News:Coway Announces New Anti-Flu Air Filter Can Inactivate 2009 Seasonal Flu Virus 2Health News:The Ensign Group to Present at Oppenheimer 20th Annual Healthcare Conference 2Health News:More Than 250 West Philadelphia Men, Women and Children are Expected to Attend Wellness for Life Event 2Health News:President Selected to Open Sanford-Brown Institute - Grand Rapids 2Health News:Smith & Nephew Orthopaedics Donates Inaugural Funds to COTA Grants Program 2Health News:Smith & Nephew Orthopaedics Donates Inaugural Funds to COTA Grants Program 3Health News:Geneticists hunt for scleroderma triggers 2
... The intra-operative MR system ... intra-operative tool for radiologists ... goal of the system ... valuable adjunct to standard ...
... By combining intra-operative ultrasound ... Medtronic Surgical Navigation Technologies ... product called SonoNav Intra-operative ... built on the high ...
... two-component fibrin sealant vapor heated ... commercially available fibrin sealant in ... are used for two specific ... to seal tissue. Both of ...
... With Plasmaseal's Proteus device the two ... blood is injected into Proteus' single use ... action base unit. The operator touches a ... plasma is separated by centrifugation. Then the ...
Medicine Products: